Durable HIV treatment benefit despite low-level viremia: reassessing definitions of success or failure

Editorial

S G Deeks. JAMA. 2001.

. 2001 Jul 11;286(2):224-6.

doi: 10.1001/jama.286.2.224.

No abstract available

Comment on

Prevalence and predictive value of intermittent viremia with combination hiv therapy.
Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK. Havlir DV, et al. JAMA. 2001 Jul 11;286(2):171-9. doi: 10.1001/jama.286.2.171. JAMA. 2001. PMID: 11448280
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D. Hermankova M, et al. JAMA. 2001 Jul 11;286(2):196-207. doi: 10.1001/jama.286.2.196. JAMA. 2001. PMID: 11448283